ES2091161A1 - Process for the production of intramuscular gamma globulin inactivated by pasteurization - Google Patents

Process for the production of intramuscular gamma globulin inactivated by pasteurization

Info

Publication number
ES2091161A1
ES2091161A1 ES09500730A ES9500730A ES2091161A1 ES 2091161 A1 ES2091161 A1 ES 2091161A1 ES 09500730 A ES09500730 A ES 09500730A ES 9500730 A ES9500730 A ES 9500730A ES 2091161 A1 ES2091161 A1 ES 2091161A1
Authority
ES
Spain
Prior art keywords
pasteurization
intramuscular
inactivated
production
gamma globulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09500730A
Other languages
Spanish (es)
Other versions
ES2091161B1 (en
Inventor
Debart Pere Ristol
Torrecillas David Camarero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Grifols SA
Original Assignee
Grifols SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grifols SA filed Critical Grifols SA
Priority to ES9500730A priority Critical patent/ES2091161B1/en
Publication of ES2091161A1 publication Critical patent/ES2091161A1/en
Application granted granted Critical
Publication of ES2091161B1 publication Critical patent/ES2091161B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

Process for the production of intramuscular gamma globulin inactivated by pasteurization. Process for the preparation of multipurpose or specific intramuscular gamma globulins which includes a stage of specific viral inactivation by pasteurization in solution. Under the conditions of the process according to this invention no significant change in the Ig molecules or their biological antibody activities, or the presence of aggregate or denatured molecular forms, is detected. It has antitetanus, antihepatitis and anti-D (Rh) applications.
ES9500730A 1995-04-12 1995-04-12 PROCEDURE FOR THE PRODUCTION OF INTRAMUSCULAR GAMMAGLOBULIN INACTIVATED BY PASTEURIZATION. Expired - Fee Related ES2091161B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9500730A ES2091161B1 (en) 1995-04-12 1995-04-12 PROCEDURE FOR THE PRODUCTION OF INTRAMUSCULAR GAMMAGLOBULIN INACTIVATED BY PASTEURIZATION.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9500730A ES2091161B1 (en) 1995-04-12 1995-04-12 PROCEDURE FOR THE PRODUCTION OF INTRAMUSCULAR GAMMAGLOBULIN INACTIVATED BY PASTEURIZATION.

Publications (2)

Publication Number Publication Date
ES2091161A1 true ES2091161A1 (en) 1996-10-16
ES2091161B1 ES2091161B1 (en) 1997-05-16

Family

ID=8290085

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9500730A Expired - Fee Related ES2091161B1 (en) 1995-04-12 1995-04-12 PROCEDURE FOR THE PRODUCTION OF INTRAMUSCULAR GAMMAGLOBULIN INACTIVATED BY PASTEURIZATION.

Country Status (1)

Country Link
ES (1) ES2091161B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2381828A1 (en) * 2012-03-20 2012-06-01 Grifols, S.A. Process for obtaining an IgG composition through heat treatment

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
EP0196761A2 (en) * 1985-02-21 1986-10-08 Green Cross Corporation Method of virus-inactivating heat treatment of gamma-globulin
EP0278422A2 (en) * 1987-02-06 1988-08-17 Green Cross Corporation y-Globulin injectable solutions
ES2034999T3 (en) * 1986-07-09 1993-04-16 Green Cross Corporation PROCEDURE FOR THERMAL TREATMENT OF GAMMA-GLOBULIN CHEMICALLY NOT MODIFIED.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
EP0196761A2 (en) * 1985-02-21 1986-10-08 Green Cross Corporation Method of virus-inactivating heat treatment of gamma-globulin
ES2034999T3 (en) * 1986-07-09 1993-04-16 Green Cross Corporation PROCEDURE FOR THERMAL TREATMENT OF GAMMA-GLOBULIN CHEMICALLY NOT MODIFIED.
EP0278422A2 (en) * 1987-02-06 1988-08-17 Green Cross Corporation y-Globulin injectable solutions

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2381828A1 (en) * 2012-03-20 2012-06-01 Grifols, S.A. Process for obtaining an IgG composition through heat treatment
EP2641912A1 (en) 2012-03-20 2013-09-25 Grifols, S.A. Process for obtaining an IgG composition through heat treatment
CN103319592A (en) * 2012-03-20 2013-09-25 基立福有限公司 Process for obtaining an IgG composition through heat treatment
AU2013201853B2 (en) * 2012-03-20 2014-07-03 Grifols, S.A. Process for obtaining an lgG composition through heat treatment
US9200032B2 (en) 2012-03-20 2015-12-01 Grifols, S.A. Process for obtaining an IgG composition through heat treatment
CN103319592B (en) * 2012-03-20 2020-03-03 基立福有限公司 Method for obtaining an IgG composition by heat treatment

Also Published As

Publication number Publication date
ES2091161B1 (en) 1997-05-16

Similar Documents

Publication Publication Date Title
PT994903E (en) METHODS AND COMPOSITIONS FOR GALACTOSILED GLICOPROTEINS
ATE425989T1 (en) PROTEIN PURIFICATION PROCESS
EP1801591A3 (en) Methods for detection or measurement of viruses
DE60207848D1 (en) METHOD FOR THE PRODUCTION OF CONCENTRATED HUMAN IMMUNOGLOBULINS FOR THERAPEUTIC USE
DE69424545D1 (en) METHOD FOR PRODUCING IMMUNOGLOBULIN G CONCENTRATE
AR248044A1 (en) Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5.
ATE367830T1 (en) DEVICE FOR INACTIVATION OF VIRAL CONTAMINATIONS IN BLOOD PRODUCTS
NZ237666A (en) Hiv envelope (env) polypeptides, antibodies and compositions for treating aids
DE69839218D1 (en) METHOD FOR REMOVING VIRUSES
PL340449A1 (en) Highly efficient method of functionally classifying proteins identified by gnomic techniques
ATE278785T1 (en) NEW METHOD FOR OBTAINING AND PURIFYING FUSION PROTEINS
DE69626683D1 (en) METHOD FOR DETECTING ANTIPOLYMER ANTIBODIES AND DIAGNOSTIC TEST SET FOR DETECTING SILICONE-DEPENDENT DISEASES
ATE212065T1 (en) NUCLEIC ACID MOLECULES WITH THE CAPABILITY OF DISTINCTING PRPC AND PRPSC PRION PROTEIN ISOFORMS AND METHODS FOR THE PRODUCTION THEREOF
ES2148577T3 (en) ELIMINATION OF INTERFERENCES CAUSED BY RHEUMATOID FACTORS THROUGH ANTI-FD ANTIBODIES.
ATE206621T1 (en) IL-8 ANTAGONISTS FOR THE TREATMENT OF ASTHMA
ES2091161A1 (en) Process for the production of intramuscular gamma globulin inactivated by pasteurization
ES2100340T3 (en) SYNTHETIC CDW52 PEPTIDIC ANTIGEN (CAMPATH-1).
ATE461935T1 (en) METHOD FOR PURIFYING STRONGLY ANIONIC PROTEINS
ATE227307T1 (en) METHOD FOR PRODUCING MODIFIED PROTEINS
ATE214430T1 (en) METHOD FOR DETECTING LIVE MICROBIOLOGICAL CONTAMINANTS IN A FOOD SAMPLE
EP1104310A4 (en) Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response
MX9605278A (en) Process for virus inactivation in proteins.
ATE229339T1 (en) INHIBITOR OF IMMUNOGLOBULIN E ANTIBODIES GENERATION FOR THE TREATMENT OF TYPE I ALLERGY-RELATED DISEASES
ATE309371T1 (en) PROTEIN WITH DNASE ACTIVITY
DK0774119T3 (en) Oligomeric carrier molecules having defined groups and haptenes incorporated in a defined manner

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19961016

Kind code of ref document: A1

Effective date: 19961016

EC2A Search report published

Date of ref document: 19961016

Kind code of ref document: A1

Effective date: 19961016

FD2A Announcement of lapse in spain

Effective date: 20150826